BCL2 and cancer: The anti-apoptotic BCL-2 proteins can be counterbalanced by proapoptotic BH3-only BCL-2 proteins; as such, the BH-3 mimetics were developed to promote apoptosis in cancer cells (Fig. 2) [36, 42, 43].